US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 4.330
  • -0.350-7.48%
Trading May 14 15:28 ET
296.26MMarket Cap-2.17P/E (TTM)

Olema Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1.56%34.87M
35.53%142.26M
20.88%36.77M
61.17%37.62M
55.22%33.53M
16.00%34.34M
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
Selling and administrative expenses
-4.65%4.25M
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-General and administrative expense
-4.65%4.25M
-5.74%17.74M
-1.65%4.47M
13.01%4.4M
22.40%4.42M
-34.24%4.46M
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
Research and development costs
2.48%30.62M
44.55%124.52M
24.84%32.3M
70.80%33.23M
61.82%29.11M
30.92%29.88M
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
Operating profit
-1.56%-34.87M
-35.53%-142.26M
-20.88%-36.77M
-61.17%-37.62M
-55.22%-33.53M
-16.00%-34.34M
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
Net non-operating interest income expense
34.96%4.52M
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
Non-operating interest income
34.96%4.52M
52.34%12.68M
-7.24%3.29M
52.58%2.93M
100.52%3.11M
156.86%3.35M
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
Other net income (expense)
-335.29%-40K
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
Other non- operating income (expenses)
-335.29%-40K
636.84%102K
-200.00%-93K
274.68%138K
190.91%40K
54.55%17K
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
Income before tax
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
Income tax
Net income
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
Net income continuous Operations
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
Minority interest income
Net income attributable to the parent company
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
1.88%-30.39M
-33.95%-129.47M
-25.38%-33.57M
-60.71%-34.56M
-51.19%-30.38M
-9.49%-30.97M
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
Basic earnings per share
35.71%-0.36
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
Diluted earnings per share
35.71%-0.36
-2.80%-2.2
16.67%-0.4
-25.00%-0.6
-10.20%-0.54
20.00%-0.56
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1.56%34.87M35.53%142.26M20.88%36.77M61.17%37.62M55.22%33.53M16.00%34.34M-1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M
Selling and administrative expenses -4.65%4.25M-5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M
-General and administrative expense -4.65%4.25M-5.74%17.74M-1.65%4.47M13.01%4.4M22.40%4.42M-34.24%4.46M-23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M
Research and development costs 2.48%30.62M44.55%124.52M24.84%32.3M70.80%33.23M61.82%29.11M30.92%29.88M4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M
Operating profit -1.56%-34.87M-35.53%-142.26M-20.88%-36.77M-61.17%-37.62M-55.22%-33.53M-16.00%-34.34M1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M
Net non-operating interest income expense 34.96%4.52M52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M
Non-operating interest income 34.96%4.52M52.34%12.68M-7.24%3.29M52.58%2.93M100.52%3.11M156.86%3.35M273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M
Other net income (expense) -335.29%-40K636.84%102K-200.00%-93K274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K
Other non- operating income (expenses) -335.29%-40K636.84%102K-200.00%-93K274.68%138K190.91%40K54.55%17K29.63%-19K38.81%93K34.17%-79K-320.00%-44K
Income before tax 1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M
Income tax
Net income 1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M
Net income continuous Operations 1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M
Minority interest income
Net income attributable to the parent company 1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 1.88%-30.39M-33.95%-129.47M-25.38%-33.57M-60.71%-34.56M-51.19%-30.38M-9.49%-30.97M7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M
Basic earnings per share 35.71%-0.36-2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49
Diluted earnings per share 35.71%-0.36-2.80%-2.216.67%-0.4-25.00%-0.6-10.20%-0.5420.00%-0.5618.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More